Literature DB >> 11641237

Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals.

D Enshell-Seijffers1, L Smelyanski, N Vardinon, I Yust, J M Gershoni.   

Abstract

Understanding the dynamics of the humoral immune response to HIV epitopes in the presence of genetic drift and antigenic variation of the virus may reveal critical elements of protective immunity against HIV. Analysis of antibody maturation and diversity is difficult to study at the molecular level in humans. We used a combinatorial phage display peptide library to elucidate antibody diversity in HIV-infected individuals to a single immunodominant epitope in gp41. A serum sample derived from an HIV+ individual was used to screen a phage display a 12 mer cysteine-constrained loop peptide library. In doing so, we isolated mimotope-presenting phages corresponding to the immunodominant gp41 epitope CSGKLIC (residues 603-609). The mimotopes and control phages expressing epitope variants were reacted with a panel of 30 HIV+ sera. The patients showed distinct and variable recognition patterns compared with one another. Subfractions of the polyclonal sera were affinity purified and analyzed for epitope specificities. These analyses illustrated that epitope variants can be used to decipher antibody diversity. Elucidation of the plasticity of the humoral response and its polyclonality toward discrete epitopes contributes to our understanding of the antibody maturation process in individuals infected with viruses such as HIV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641237     DOI: 10.1096/fj.00-0898com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

1.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 2.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

3.  Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.

Authors:  Barbara C Bachler; Michael Humbert; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2013-06-21       Impact factor: 4.602

Review 4.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

5.  Site directed biotinylation of filamentous phage structural proteins.

Authors:  Larisa Smelyanski; Jonathan M Gershoni
Journal:  Virol J       Date:  2011-11-01       Impact factor: 4.099

6.  Mimotopes selected with a neutralizing antibody against urease B from Helicobacter pylori induce enzyme inhibitory antibodies in mice upon vaccination.

Authors:  Yan Li; Yunshan Ning; Yundan Wang; Dandan Peng; Yaodong Jiang; Lili Zhang; Min Long; Jun Luo; Ming Li
Journal:  BMC Biotechnol       Date:  2010-11-30       Impact factor: 2.563

7.  Motifier: An IgOme Profiler Based on Peptide Motifs Using Machine Learning.

Authors:  Haim Ashkenazy; Oren Avram; Arie Ryvkin; Anna Roitburd-Berman; Yael Weiss-Ottolenghi; Smadar Hada-Neeman; Jonathan M Gershoni; Tal Pupko
Journal:  J Mol Biol       Date:  2021-05-28       Impact factor: 6.151

8.  Purification of polyclonal anti-conformational antibodies for use in affinity selection from random peptide phage display libraries: a study using the hydatid vaccine EG95.

Authors:  A J Read; C G Gauci; M W Lightowlers
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-28       Impact factor: 3.205

9.  Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.

Authors:  Tessa Dieltjens; Leo Heyndrickx; Betty Willems; Elin Gray; Lies Van Nieuwenhove; Katrijn Grupping; Guido Vanham; Wouter Janssens
Journal:  Retrovirology       Date:  2009-12-14       Impact factor: 4.602

10.  Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing.

Authors:  Michael Humbert; Robert A Rasmussen; Helena Ong; Fabian M P Kaiser; Shiu-Lok Hu; Ruth M Ruprecht
Journal:  PLoS One       Date:  2008-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.